472 studies found for:    Thrombocytopenia: Clinical Trials
Show Display Options
RSS Create an RSS feed from your search for:
Thrombocytopenia: Clinical Trials
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting WEUSKOP5410: Observational Study in ENABLE Clinical Trials
Conditions: Phlebitis;   Hepatitis C;   Unstable Angina;   Deep Vein Thrombosis;   Ischemic Stroke;   Pulmonary Embolism;   Ischaemic Attack, Transient;   Thrombocytopenia;   Thrombophlebitis;   Myocardial Infarction;   Portal Vein Thrombosis
Intervention: Drug: eltrombopag
2 Recruiting A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia
Conditions: Anemia, Aplastic;   Anemia, Hypoplastic;   Thrombocytopenia
Interventions: Drug: Eltrombopag (Promacta);   Drug: Eltrombopag
3 Not yet recruiting A Study to Investigate Belimumab for the Treatment of Chronic Immune Thrombocytopenia.
Condition: Purpura, Thrombocytopaenic, Idiopathic
Interventions: Drug: Belimumab;   Drug: Normal saline placebo
4 Active, not recruiting Study of a New Medication for Childhood Chronic Immune Thrombocytopenia (ITP), a Blood Disorder of Low Platelet Counts That Can Lead to Bruising Easily, Bleeding Gums, and/or Bleeding Inside the Body.
Condition: Oedema
Interventions: Drug: Eltrombopag;   Drug: Placebo
5 Completed Heparin-Induced Thrombocytopenia - Retrospective Analysis of Data on Incidence and Outcomes Study
Condition: Heparin Induced Thrombocytopenia
Intervention:
6 Active, not recruiting A Prospective, Study Evaluating Changes in Bone Marrow Morphology in Adult Subjects Receiving Romiplostim for the Treatment of Thrombocytopenia Associated With Immune (Idiopathic) Thrombocytopenia Purpura (ITP)
Conditions: Thrombocytopenia;   Idiopathic Thrombocytopenic Purpura
Intervention: Biological: romiplostim
7 Unknown  A Study on the Prevalence of Heparin-Induced Thrombocytopenia in Cardiovascular Patients
Condition: Heparin-Induced Thrombocytopenia
Intervention:
8 Recruiting A Three-part Study of Eltrombopag in Thrombocytopenic Subjects With Myelodysplastic Syndromes or Acute Myeloid Leukemia
Condition: Thrombocytopaenia
Interventions: Drug: eltrombopag;   Drug: placebo
9 Unknown  The HIT-TRAP Trial
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: Standard heparin (UFH) versus certoparin (LMWH)
10 Completed Efficacy and Safety Study of Argatroban to Treat Heparin-Induced Thrombocytopenia
Condition: Heparin-Induced Thrombocytopenia
Intervention: Drug: argatroban
11 Completed An Open-label Safety Study of S-888711
Condition: Immune Thrombocytopenia
Intervention: Drug: 0.5 mg of S-888711
12 Recruiting A Single Arm Pilot Study of Azacitidine in Myelodysplastic Syndromes (MDS) / Acute Myeloid Leukaemia (AML), With Eltrombopag Support for Thrombocytopenia
Conditions: Myelodysplastic Syndromes (MDS);   Acute Myeloid Leukaemia (AML)
Intervention: Drug: Azacitidine and eltrombopag
13 Completed Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide
Conditions: Sarcoma;   Thrombocytopenia;   Thrombocytopaenia;   Thrombopoiesis
Intervention: Drug: eltrombopag
14 Terminated A Study to Investigate the Efficacy and Safety of S-888711 Tablets Administered to Adult Subjects With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Interventions: Drug: placebo to S-888711;   Drug: S-888711
15 Terminated Safety/Efficacy Study of a Drug to Reduce Thrombocytopenia in Patients Receiving Chemotherapy for Ovarian, Fallopian Tube or Peritoneal Cancer
Conditions: Thrombocytopenia;   Neutropenia;   Lymphopenia;   Anemia
Intervention: Drug: Angiotensin 1-7
16 Completed SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C
Conditions: Hepatitis C, Chronic;   Hepatitis C;   Thrombocytopenia
Interventions: Drug: SB497115;   Other: Placebo
17 Recruiting Safety and Efficacy Study for Solid Tumor Patients Treated With Eltrombopag
Condition: Thrombocytopaenia
Interventions: Drug: Eltrombopag olamine;   Other: Placebo
18 Recruiting A Study of the Safety and Efficacy of ONO-7746 in Adult Cancer Patients With Chemotherapy Induced Thrombocytopenia
Condition: Chemotherapy-Induced Thrombocytopenia
Intervention: Drug: ONO-7746
19 Terminated
Has Results
Evaluating the Presence of Blood Clots in People With Heparin-Induced Thrombocytopenia (HIT) (The HOT Study)
Condition: Thrombocytopenia
Intervention:
20 Recruiting Rivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced Thrombocytopenia
Condition: Heparin-induced Thrombocytopenia
Intervention: Drug: Rivaroxaban

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years